Next Gen Biotech

Leuprosun 22.5 mg Injection contains Leuprolide Acetate, a synthetic gonadotropin-releasing hormone (GnRH) agonist. It is used in the palliative treatment of advanced prostate cancer. The injection is administered once every three months (84 days) and works by reducing testosterone levels, thereby slowing the growth of cancer cells.

BDSURE 11.25 mg Injection contains Leuprolide Acetate, a synthetic gonadotropin-releasing hormone (GnRH) agonist. It is used in the treatment of prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The injection is administered once every three months and works by decreasing the levels of certain hormones, thereby slowing disease progression.

Leuprosun 11.25 mg Injection contains Leuprolide Acetate, a synthetic gonadotropin-releasing hormone (GnRH) agonist. It is used in the palliative treatment of advanced prostate cancer in men and in the management of endometriosis and uterine fibroids in women. The injection is administered once every three months and works by decreasing the levels of certain hormones, thereby slowing disease progression.